Pacira Pharmaceuticals, Inc.【PCRX】 株式報酬費用の推移

機能の使い方
(単位:千ドル) 株式報酬費用 前年比(%)
2024/12 51,171 +6.8%
2023/12 47,895 -0.4%
2022/12 48,092 +13.8%
2021/12 42,246 +5.8%
2020/12 39,920 +18.6%
2019/12 33,650 +6.1%
2018/12 31,725 +0.4%
2017/12 31,601 +1.1%
2016/12 31,248 -6.4%
2015/12 33,368 +34.4%
2014/12 24,822 +115.6%
2013/12 11,513 +141.1%
2012/12 4,776 +91.6%
2011/12 2,493 -